Abstract
The success of anti-cancer therapy largely relies on the development of high-efficient, low-toxic, long-circulated, and cancertargeted drug delivery systems. Currently used pharmaceutical nanocarriers, such as polymeric nanoparticles (NPs), liposomes, micelles, nanoemulsions, and many others demonstrate a variety of useful properties, including long circulation in the blood allowing for their accumulation in cancer sites with fenestrated vasculature and poor lymphatic drainage. Surface-modification of nanocarriers is attractive for their enhanced functions on imaging, targeting and delivery. Due to various targeting ligands attached to the surface of the nanocarriers, they could prolong circulation time, increase drug bioavailability, reduce undesirable side effects, and minimize non-specific uptake thus allow for specific cancer-targeting to certain target cells within the cancer sites or even intracellular localization to target organelles. This review highlights the different types of the surface modification of various drug or gene loaded nanocarriers for cancer therapy, focusing on their modification methods, advantages, applications and the probable associated drawbacks.
Keywords: Nanocarriers, surface-modification, cancer therapy, drug and gene delivery
Current Nanoscience
Title: Surface Modification of Nanocarriers for Cancer Therapy
Volume: 5 Issue: 2
Author(s): Wang-yang Yu and Na Zhang
Affiliation:
Keywords: Nanocarriers, surface-modification, cancer therapy, drug and gene delivery
Abstract: The success of anti-cancer therapy largely relies on the development of high-efficient, low-toxic, long-circulated, and cancertargeted drug delivery systems. Currently used pharmaceutical nanocarriers, such as polymeric nanoparticles (NPs), liposomes, micelles, nanoemulsions, and many others demonstrate a variety of useful properties, including long circulation in the blood allowing for their accumulation in cancer sites with fenestrated vasculature and poor lymphatic drainage. Surface-modification of nanocarriers is attractive for their enhanced functions on imaging, targeting and delivery. Due to various targeting ligands attached to the surface of the nanocarriers, they could prolong circulation time, increase drug bioavailability, reduce undesirable side effects, and minimize non-specific uptake thus allow for specific cancer-targeting to certain target cells within the cancer sites or even intracellular localization to target organelles. This review highlights the different types of the surface modification of various drug or gene loaded nanocarriers for cancer therapy, focusing on their modification methods, advantages, applications and the probable associated drawbacks.
Export Options
About this article
Cite this article as:
Yu Wang-yang and Zhang Na, Surface Modification of Nanocarriers for Cancer Therapy, Current Nanoscience 2009; 5 (2) . https://dx.doi.org/10.2174/157341309788185370
DOI https://dx.doi.org/10.2174/157341309788185370 |
Print ISSN 1573-4137 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6786 |
Call for Papers in Thematic Issues
Role of nanomaterials in fabrication of coatings, Machining and Joining
The application of nanoscience has brought about a revolution in the field of mechanical engineering by providing novel materials, boosting manufacturing processes, and generating cutting-edge products. The purpose of this special issue is to investigate the enormous impact that nanoscience has had on mechanical engineering, with a particular emphasis on ...read more
Advanced Inorganic Nanocomposites and Their Emerging Applications
This special issue collection will highlight developments on the recent trends about the synthesis of metal oxides, nanoclusters, biomaterials, 2D nanomaterials, nanocrystals, nanocomposites, etc. and their applications in electrochemical systems, tissue regeneration, energy storage and harvesting, sensors, etc. The novelty of the methods in the chemical synthesis and their characterizations, ...read more
Applicability of Nanotechnology for Performance Enhancement of Clean Energy Technologies
Population growth, industrialization, and improvement in living quality would lead to further increase in energy demand in near future. Regarding the disadvantages of fossil fuels such as fluctuations in their price, high emissions of greenhouse gases and restriction of their sources, it is crucial to use and exploit alternative energy ...read more
Graphene and 2D Materials for Energy Storage and Conversion
This thematic issue will discuss the recent advances in graphene-based nanomaterials for different energy technologies. Graphene possesses a high surface area, and stable structure and exhibits many interesting electronic, optical, and mechanical properties due to its 2D crystal structure. Graphene is of both fundamental interest and suitable for a wide ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Alkaloids from Cyanobacteria with Diverse Powerful Bioactivities
Mini-Reviews in Medicinal Chemistry Recent Progress in Gene Therapy for Parkinson’s Disease
Current Molecular Medicine Pore-forming Peptides: A New Treatment Option for Cancer
Current Medicinal Chemistry Intra-arterial Temozolomide, Osmotic Blood-brain Barrier Disruption and Radiotherapy in a Rat F98-Glioma Model
Clinical Cancer Drugs Inhibitory Smad7: Emerging Roles in Health and Disease
Current Molecular Pharmacology The History of the HSV Amplicon: From Naturally Occurring Defective Genomes to Engineered Amplicon Vectors
Current Gene Therapy Graphene Oxide: A Carrier for Pharmaceuticals and a Scaffold for Cell Interactions
Current Topics in Medicinal Chemistry Intraoperative Targeted Optical Imaging: A Guide towards Tumor-Free Margins in Cancer Surgery
Current Pharmaceutical Biotechnology New Developments in Anti-Angiogenic Therapy of Cancer, Review and Update
Anti-Cancer Agents in Medicinal Chemistry Mesenchymal Stem Cells Promote Caspase Expression in Molt-4 Leukemia Cells <i>Via</i> GSK-3α/Β and ERK1/2 Signaling Pathways as a Therapeutic Strategy
Current Gene Therapy Editorial (Personalized Medicine in the Age of Pharmacoproteomics: A Close up on India and Need for Social Science Engagement for Responsible Innovation in Post-Proteomic Biology)
Current Pharmacogenomics and Personalized Medicine Convection-Enhanced Delivery: Neurosurgical Issues
Current Drug Targets Recent Developments in the Chemical Biology of Epothilones
Current Pharmaceutical Design Glucose-6-Phosphate Dehydrogenase Deficiency: Disadvantages and Possible Benefits
Cardiovascular & Hematological Disorders-Drug Targets Green Tea Catechins as Novel Antitumor and Antiangiogenic Compounds
Current Medicinal Chemistry - Anti-Cancer Agents Natural Polymeric Nanoparticles for Brain-Targeting: Implications on Drug and Gene Delivery
Current Pharmaceutical Design Glycogen Synthase Kinase 3 as an Anticancer Drug Target: Novel Experimental Findings and Trends in the Design of Inhibitors
Current Pharmaceutical Design Valproic Acid As Anti-Cancer Drug
Current Pharmaceutical Design Eph Receptors as Drug Targets: Single-Chain Antibodies and Beyond
Current Drug Targets Structure of the Epidermal Growth Factor Receptor Gene and Intron Recombination in Human Gliomas
Current Genomics